Integrative Care and Its Key Components For Reducing Obesity

Find effective solutions for obesity through integrative care practices that support wellness and improve quality of life.

Abstract

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this educational post, I guide you through a clear, first-person journey connecting obesity, polycystic ovary syndrome (PCOS), fertility, pregnancy, sleep, mental health, and long-term metabolic health. I explain how insulin resistance, chronic inflammation, and autonomic imbalance drive reproductive and cardiometabolic risks; why GLP-1 and GIP/GLP-1 therapies, metformin, and targeted psychopharmacology can help; and how integrative chiropractic care improves neuromusculoskeletal function, autonomic balance, pain control, and adherence to lifestyle change. I also detail our multidisciplinary model at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, where I work closely with Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), our Medical Director and Collaborative Physician with more than 40 years of experience. Together, we integrate internal medicine, chiropractic, functional medicine, rehabilitation, and personal injury services to support patients before conception, through pregnancy, and into the postpartum period and long-term health.

Our Integrative Care Team: Internal Medicine Direction With Chiropractic and Functional Medicine

At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, our care model unifies evidence-based internal medicine oversight with integrative chiropractic and functional medicine. I lead neuromusculoskeletal care, rehabilitation planning, and functional medicine protocols. Dr. Maria Guadalupe Cardenas, MD, our Medical Director and Collaborative Physician, provides medical direction, risk stratification, and pharmacologic stewardship. This multidisciplinary setup—common in integrative and injury care clinics—allows us to safely coordinate complex care plans while addressing the root causes of disease and the practical barriers that keep patients from healing.

• What I do (Dr. Jimenez):

• • Deliver chiropractic care to improve spine and joint mechanics, reduce pain, and modulate the autonomic nervous system to shift from sympathetic overdrive to parasympathetic balance.
  • Lead functional medicine strategies: nutrition planning, micronutrient repletion, gut-metabolic support, circadian and stress optimization.
  • Coordinate rehabilitation and movement prescriptions that build sustainable exercise capacity and protect from injury.

• What Dr. Cardenas does (Internal Medicine):

• • Provides medical oversight for metabolic and cardiometabolic conditions, pregnancy-related risk, and medication management.
  • Supervises pharmacotherapy (e.g., metformin, GLP-1 receptor agonists like semaglutide, GIP/GLP-1 dual agonists like tirzepatide, statins, antihypertensives, and carefully selected psychotropics).
  • Monitors labs and safety (A1C, fasting insulin, lipids, liver enzymes, blood pressure) and coordinates with obstetrics, psychiatry, cardiology, and lactation services.

• How this helps you:

• • We blend root-cause strategies with precise medical care.
  • We reduce pain and autonomic stress, making it easier to move, sleep, and adhere to nutrition and activity plans.
  • We sustain continuity of care from preconception through the postpartum period and beyond.

PCOS and Insulin Resistance: The Venn Diagram of Obesity, Hormones, and Metabolism

I see polycystic ovary syndrome (PCOS) frequently in women of reproductive age. PCOS is a chronic endocrine disorder with reproductive, neuroendocrine, and metabolic consequences that persist across the lifespan (Azziz et al., 2016; Escobar-Morreale, 2018). It commonly overlaps with obesity and insulin resistance, creating a self-reinforcing triad that drives hyperinsulinemia, hyperandrogenism, ovulatory dysfunction, dyslipidemia, and cardiometabolic risk (Teede et al., 2018).

• Common PCOS features:

• • Menstrual irregularity (oligomenorrhea, amenorrhea)
  • Hyperandrogenism (acne, hirsutism, hair loss)
  • Insulin resistance and dyslipidemia
  • Chronic low-grade inflammation
  • High co-prevalence of obesity (often 60–80%)

• Why insulin resistance matters:

• • Hyperinsulinemia stimulates ovarian androgen production and alters hypothalamic-pituitary-ovarian feedback, impairing ovulation (Azziz et al., 2016; Escobar-Morreale, 2018).
  • Drives dyslipidemia, prediabetes, type 2 diabetes, cardiovascular risk, and liver fat accumulation (now termed MASLD).
  • Promotes fat storage and makes weight loss more difficult, creating a feed-forward loop.

• Diagnosis (Rotterdam 2003): Two of three, after excluding mimics:

• • Hyperandrogenism (clinical or biochemical)
  • Ovulatory dysfunction
  • Polycystic ovarian morphology on ultrasound

In primary care and obesity-focused settings, we often diagnose based on history and labs without immediate ultrasound when appropriate (Teede et al., 2018).

• Complications if unmanaged:

• • Reproductive: infertility, miscarriage, gestational diabetes, preeclampsia, prematurity
  • Metabolic: metabolic syndrome, type 2 diabetes
  • Cardiovascular: hypertension, dyslipidemia, atherosclerotic risk
  • Liver: MASLD
  • Cancer: increased endometrial risk due to infrequent shedding
  • Mental health: depression, anxiety, disordered eating
  • Sleep: strong association with obstructive sleep apnea (OSA)

• Physiological underpinnings in brief:

• • Excess adiposity increases adipokine dysregulation (reduced adiponectin, increased leptin), inflammatory cytokines (TNF-α, IL-6), and oxidative stress, which impair insulin signaling and endothelial function.
  • Insulin resistance increases ovarian theca cell androgen production; hyperandrogenism further worsens central adiposity and insulin resistance.

Evidence-Based Treatment for PCOS and Obesity: Nutrition, Movement, Medications, and Chiropractic Integration

Our priority is to reduce adiposity and improve insulin sensitivity. Even a 5–7% weight reduction can restore menstrual regularity and spontaneous ovulation (Teede et al., 2018). Because fertility can return quickly at the start of treatment, we discuss contraception when pregnancy is not immediately desired.

• Nutrition to reduce insulin spikes:

• • Prioritize protein and fiber to support satiety hormones (PYY, GLP-1) and stabilize glycemia.
  • Reduce ultra-processed foods, starches, sweets, refined grains, and alcohol to lower postprandial insulin.
  • Consider smaller, more frequent meals to minimize large insulin excursions and maintain energy stability.

• Activity to enhance insulin sensitivity:

• • Short, frequent cardio (e.g., three 10-minute bouts) can outperform a single continuous session for glycemic improvement in day-to-day life.
  • Resistance training 1–2 times/week builds metabolically active muscle, increasing GLUT4 translocation and improving glucose disposal.

• Medical and pharmacologic support (Internal Medicine oversight):

• • Metformin ER: Improves hepatic gluconeogenesis and peripheral insulin sensitivity; I start low (e.g., 500 mg ER) and titrate for tolerability (Rena et al., 2017).
  • GLP-1 receptor agonists (e.g., semaglutide) and GIP/GLP-1 dual agonists (e.g., tirzepatide): Produce significant weight loss, improve satiety, and enhance glycemic control (Wilding et al., 2021; Jastreboff et al., 2022).
  • Combined oral contraceptives: Regulate menses and protect endometrium; spironolactone for acne/hirsutism when indicated.

• Chiropractic and autonomic regulation:

• • Chronic stress elevates cortisol, worsening insulin resistance and inflammation. Chiropractic adjustments, gentle mobilization, and breathing retraining can help shift autonomic tone toward the parasympathetic, reduce pain, and enable consistent movement and sleep—both critical for metabolic stability.

• Why this works physiologically:

• • Lower glycemic variability reduces compensatory hyperinsulinemia and lipogenesis.
  • Muscle contraction increases insulin-independent glucose uptake and insulin sensitivity.
  • GLP-1/GIP signaling improves satiety, delays gastric emptying, and fine-tunes insulin/glucagon secretion, thereby reducing caloric intake and postprandial spikes.
  • Metformin activates AMPK, promoting fatty acid oxidation and improved insulin signaling (Rena et al., 2017).
  • Pain reduction and autonomic balance lower stress-driven cravings and facilitate exercise adherence.

Maternal Metabolic Health: Preconception to Postpartum With Compassionate, Weight-Inclusive Care

Pregnancy amplifies insulin resistance to prioritize fetal glucose. In women with obesity and underlying insulin resistance, this physiologic shift is intensified. Elevated maternal lipids and glycemia cross the placenta, shaping fetal metabolic programming and increasing the child’s later risk for obesity and type 2 diabetes (Catalano & deMouzon, 2015).

• Maternal risks increased by obesity:

• • Gestational diabetes and macrosomia
  • Hypertensive disorders of pregnancy including preeclampsia
  • Thromboembolic events (VTE) in a hypercoagulable state
  • Higher likelihood of cesarean and postoperative complications (wound infection, delayed healing)
  • Peripartum mood disorders and lactation challenges

• Physiology behind the risks:

• • Endothelial dysfunction: Oxidative stress and reduced nitric oxide increase vascular tone and blood pressure (Roberts & Hubel, 2009; Khan et al., 2022).
  • Placental maladaptation: Shallow trophoblast invasion and suboptimal remodeling of the spiral arteries impair placental perfusion (Kenny et al., 2010).
  • Hypercoagulability: Pregnancy is prothrombotic; adiposity increases coagulation activity and platelet aggregation (Knight et al., 2017).
  • Glycemic impairment: Poor glycemic control disrupts collagen synthesis and wound healing (Guo & DiPietro, 2010).

• Integrative support before and during pregnancy:

• • Preconception weight reduction: Lowers fasting insulin/glucose, reduces risk of gestational diabetes and macrosomia, improves blood pressure, lipids, and liver enzymes.
  • Medication timing: We may use metformin and, preconception, GLP-1/GIP/GLP-1 agents to facilitate weight loss; we plan discontinuation windows carefully before attempting conception per labeling and conservative clinical judgment.
  • Chiropractic and rehab: Manual therapy, gentle mobilization, and neuromuscular stabilization ease pain, improve pelvic biomechanics, facilitate early mobilization after delivery, and support autonomic balance.
  • Sleep and stress: HRV-guided breathing, mindfulness, and sleep hygiene protect blood pressure, insulin sensitivity, and mental health.

• Pregnancy weight gain is individualized based on pre-pregnancy BMI and led by the patient’s OB. Excess gain raises risks; insufficient gain can compromise fetal growth. We align lifestyle plans with OB guidance and maintain close Internal Medicine oversight.
• Breastfeeding benefits and barriers:

• • Benefits for mother: reduced type 2 diabetes, CVD, and certain cancers (Chowdhury et al., 2014; Peters et al., 2017).
  • Benefits for infant: improved immunity, lower lifetime cardiometabolic
  • Barriers in obesity: delayed lactogenesis II, perceived low supply, positioning difficulties, and higher C-section rates.
  • Our approach: pre-delivery education, early lactation referrals, postural and thoracic mobility support through chiropractic care, adequate caloric intake with glycemic control, and consistent follow-ups.

Epigenetics and Generational Risk: Why Maternal and Paternal Health Both Matter

Both maternal and paternal adiposity influence offspring risk of obesity, type 2 diabetes, and cardiometabolic disease (Leddy et al., 2008; Soubry, 2015). Paternal obesity is linked to altered sperm DNA methylation and small non-coding RNAs that affect embryonic development and long-term metabolic programming (Donkin & Barres, 2018). Maternal hyperglycemia and hyperinsulinemia drive fetal beta-cell hyperplasia and macrosomia, establishing a trajectory toward childhood adiposity (Catalano & deMouzon, 2015). Placental epigenetic changes modulate nutrient transport and endocrine signaling (Chavkin et al., 2022). Family-centered counseling that addresses both partners improves fertility and reduces pregnancy complications with intergenerational benefits.

Mental Health, Stress, Sleep, and Weight: Closing the Loop

Chronic stress and sleep disruption are powerful drivers of insulin resistance, overeating, and weight gain. Adipose tissue itself generates inflammatory signals, compounding the HPA axis activation of prolonged stress. In my practice, I screen for depression, anxiety, PTSD, bipolar disorder, and ADHD, and for disordered eating and eating disorders. Many psychotropics affect weight; we coordinate with mental health providers to choose weight-neutral or weight-favorable options when possible.

• Screening and care coordination:

• • Tools: PHQ-9 (depression), GAD-7 (anxiety), ASRS (ADHD), SCOFF/ESP (eating disorders).
  • For PTSD: therapy referrals (e.g., EMDR), stress regulation, and sleep hygiene are prioritized.
  • For bipolar disorder: psychiatric management is essential when considering stimulants or agents with mood effects.

• Eating disorders spectrum:

• • Anorexia nervosa, bulimia nervosa, binge eating disorder (BED), ARFID, night eating syndrome—they demand medical and psychological care. Screening catches high-risk patterns that aren’t always visible in body habitus.

• Sleep disorders and metabolism:

• • Obstructive sleep apnea (OSA) is common in obesity and disrupts ghrelin and leptin, increasing appetite and cravings while worsening cardiometabolic risk. Screening with the STOP-BANG and Epworth questionnaires, followed by sleep studies, is crucial (Kryger et al., 2022).
  • Tirzepatide has shown a>60% reduction in apnea events and up to ~20% weight reduction in moderate-to-severe OSA among patients with obesity, demonstrating the interplay between obesity treatment and sleep outcomes (AJRCCM editorial on SURMOUNT-OSA, 2024).
  • Shift work disorder misaligns circadian rhythms; management includes optimizing the sleep environment, careful timing of stimulant/wake-promoting medications, and nutrition/activity planning that supports circadian harmony.

• Chiropractic’s role:

• • By reducing pain, improving thoracic mobility and rib mechanics, and training diaphragmatic breathing, we improve sleep quality and autonomic balance—two levers that directly modulate appetite, decision-making, and exercise adherence.

Integrative Case Pathways: Translating Methods Into Outcomes

To show how these pieces fit together, here are two integrative care pathways from my practice.

Case 1: PCOS, Insulin Resistance, Mental Health Comorbidity

• Presentation: Class III obesity with PCOS, insulin resistance, prediabetes, vitamin D deficiency, binge eating, depression, and anxiety.
• Medical optimization: In collaboration with psychiatry, we moved from a more weight-promoting SSRI (e.g., paroxetine) to a more weight-neutral option (e.g., sertraline) and considered topiramate for appetite modulation while monitoring cognition and mood.
• Metabolic therapy: Metformin was initiated to improve hepatic and peripheral insulin sensitivity; semaglutide was subsequently initiated to enhance satiety and reduce caloric intake (Rena et al., 2017; Wilding et al., 2021).
• Lifestyle and chiropractic: We started with 10 minutes of movement daily, progressed resistance training, prioritized protein and fiber, and integrated spinal and pelvic adjustments and breathing drills to reduce pain and sympathetic load.
• Outcomes:

• • 3 months: ~10% total body weight reduction with improvements in triglycerides, LDL-C, and fasting insulin.
  • 6 months: ~15% total body weight reduction; waist circumference and labs continued to improve, signaling reduced visceral adiposity and better hepatic insulin sensitivity.

Case 2: Shift Work, Cardiometabolic Risk, and Long-Term Weight Health

• Presentation: 40-year-old with class III obesity, prediabetes, hypertension, hyperlipidemia, vitamin D deficiency, shift work, and persistent cravings.
• Initial therapy: Atorvastatin for dyslipidemia, metformin for insulin resistance, vitamin D repletion.
• Anti-obesity sequence: Began with semaglutide; persistent hunger led to adding phentermine after cardiology clearance (baseline EKG). Insurance shift prompted transition to tirzepatide; additional appetite control achieved with phentermine/topiramate.
• Activity and nutrition: We restructured intermittent fasting to include at least two meals within the window to ensure protein distribution and support lean mass; emphasis on reduced refined carbohydrates.
• Chiropractic and sleep: Addressed postural load and back pain to enhance exercise capacity; breathing and mobility work to reduce sympathetic overdrive and improve sleep.
• Outcomes: ~65-pound loss, ~20% total body weight reduction over the long term; broad metabolic improvements with some persistent insulin elevation typical in complex cases—managed with sustained lifestyle and pharmacotherapy synergy.
• Why these regimens worked:

• • GLP-1/GIP-GLP-1 therapies recalibrate central appetite pathways and peripheral glycemia (Drucker, 2012; Jastreboff et al., 2022).
  • Metformin reduces hepatic glucose output and improves insulin signaling (Rena et al., 2017).
  • Phentermine/topiramate targets hypothalamic catecholamines and glutamatergic appetite modulation to contain persistent hunger (Gadde et al., 2011).
  • Chiropractic improvement in mechanics and autonomic tone sustains activity and sleep, essential for durable metabolic change.

Preconception Medication Timing and Safety: Practical Guidance

When pregnancy is a goal, we plan conservative discontinuation windows for GLP-1 and GIP/GLP-1 agents and stop agents like phentermine before attempting conception. We maintain metformin when clinically appropriate and with OB oversight. Dr. Cardenas coordinates risk stratification, blood pressure and glycemic monitoring, and lab surveillance while we continue chiropractic care for pain control, mobility, and stress regulation. For postpartum and lactation, we prioritize adequate caloric intake and musculoskeletal support; we revisit anti-obesity medications after breastfeeding with shared decision-making.

Beyond Adjustments: Chiropractic and Integrative Healthcare- Video

Why Integrative Chiropractic Care Fits: Mechanisms That Support Metabolic Health

• Neuromusculoskeletal optimization: Improved alignment and segmental mobility reduce nociceptive input and facilitate efficient gait and exercise, increasing energy expenditure and lowering injury risk.
• Autonomic balance: Pain and poor mechanics heighten sympathetic drive; spinal adjustments and breathing retraining facilitate parasympathetic recovery, which supports sleep, appetite regulation, and blood pressure control.
• Behavioral adherence: Less pain and better sleep translate into more consistent nutrition preparation, exercise participation, and follow-up—vital for long-term outcomes.
• Clinical insights from my practice: Patients with lower pain and improved mechanics consistently show higher adherence to metabolic protocols, greater gains in VO2, and better weight maintenance. Short, successful daily activity (10 minutes) builds self-efficacy and naturally scales to 20–30 minutes as stamina and mechanics improve (observations shared on dralexjimenez.com and my LinkedIn).

Putting It All Together: A Unified, Evidence-Based Process

• Intake and risk stratification: Detailed history, physical, labs, and safety screening under Internal Medicine oversight.
• Chiropractic assessment: Posture, gait, pain generators, motor control deficits, and autonomic markers guide manual therapy and rehab.
• Nutrition and functional medicine: Higher protein, reduced refined carbohydrates, and fiber-rich whole foods to stabilize glycemia and support satiety; micronutrient repletion (e.g., vitamin D).
• Movement prescription: Graded aerobic and resistance training for insulin sensitivity and metabolic flexibility.
• Medication management: GLP-1/GIP-GLP-1 agents, metformin, statins, and appetite modulators tailored to phenotype and monitored closely.
• Mental health and sleep: Coordinated psychotropic optimization, counseling, and sleep disorder evaluation and treatment (e.g., OSA).
• Clinical reasoning:

• • Meaningful weight loss (≥5%) improves glycemia, blood pressure, and liver fat; 10–20% loss amplifies benefits across cardiometabolic profiles.
  • Sustained change hinges on reducing pain, restoring sleep, and stabilizing stress—hence the central role for integrative chiropractic care.
  • Interdisciplinary collaboration prevents gaps in care, especially around conception, surgery considerations (bariatric), and long-term maintenance.

References

• Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S., Legro, R. S., Lizneva, D., Natterson-Horowitz, B., Teede, H. J., & Yildiz, B. O. (2016). Polycystic ovary syndrome. Nature Reviews Disease Primers, 2(1), 16057.
• Catalano, P. M., & deMouzon, S. H. (2015). Maternal obesity and metabolic programming of offspring. Nature Reviews Endocrinology, 11(11), 653–661.
• Chowdhury, R., Sinha, B., Sankar, M. J., et al. (2014). Breastfeeding and maternal health outcomes: A systematic review and meta-analysis. BMJ, 347, f5190.
• Drucker, D. J. (2012). GLP-1 physiology informs the pharmacotherapy of obesity and diabetes. Nature Reviews Endocrinology, 8(12), 611–622.
• Escobar-Morreale, H. F. (2018). Polycystic ovary syndrome: Definition, etiology, diagnosis and treatment. Nature Reviews Endocrinology, 14(5), 270–284.
• Gadde, K. M., Allison, D. B., Ryan, D. H., et al. (2011). Effects of low-dose, controlled-release, phentermine plus topiramate on weight and associated comorbidities in overweight and obese adults. JAMA, 305(4), 373–380.
• Guo, S., & DiPietro, L. A. (2010). Factors affecting wound healing. AJP-Cell, 299(6), C1328–C1337.
• Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387, 205–216.
• Khan, K. S., Wojdyla, D., et al. (2022). Hypertensive disorders of pregnancy and long-term cardiovascular risk. Circulation Research, 131(7), 1042–1062.
• Kryger, M. H., Roth, T., & Dement, W. C. (Eds.). (2022). Principles and practice of sleep medicine (7th ed.). Elsevier.
• Peters, S. A. E., Yang, L., Guo, Y., et al. (2017). Breastfeeding and risk of maternal cardiovascular disease. JAMA, 317(3), 269–279.
• Rena, G., Hardie, D. G., & Pearson, E. R. (2017). The mechanisms of action of metformin. Diabetes, 66(10), 221–229.
• Roberts, J. M., & Hubel, C. A. (2009). The two-stage model of preeclampsia: Variations on the theme. Endocrinology, 150(8), 3527–3535.
• Soubry, A. (2015). Epigenetic inheritance and the influence of paternal obesity on spermatogenesis and offspring health. Current Opinion in Endocrinology, Diabetes and Obesity, 22(3), 211–216.
• Teede, H. J., Misso, M. L., Costello, M. F., et al. (2018). Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertility and Sterility, 110(3), 364–379.
• Wilding, J. P. H., Batterham, R. L., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384, 989–1002.
• American Journal of Respiratory and Critical Care Medicine Editorial. (2024). SURMOUNT-OSA study and tirzepatide in OSA with obesity. AJRCCM, 210(1), 15–17.

About the Author and Clinical Observations

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, leading integrative chiropractic and functional medicine care at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas. I regularly share clinical insights on dralexjimenez.com and professional updates on LinkedIn at linkedin.com/in/dralexjimenez. Over years of practice, I have observed that aligning internal medicine oversight with integrative chiropractic and functional medicine improves adherence, reduces pain, enhances sleep, and accelerates improvements in metabolic and reproductive outcomes. Our mission is to meet you where you are, personalize your plan, and support you through each phase—from preconception to postpartum and long-term health.

SEO tags: PCOS, insulin resistance, GLP-1, tirzepatide, semaglutide, metformin, preconception weight loss, pregnancy and obesity, preeclampsia prevention, gestational diabetes, obstructive sleep apnea, shift work disorder, integrative chiropractic care, functional medicine, internal medicine oversight, Dr. Maria Guadalupe Cardenas MD, Dr. Alex Jimenez DC, El Paso Injury Medical Clinic, Mission Plaza Injury Medical Clinic, lactation support, epigenetics parental obesity, MASLD, cardiometabolic risk reduction, autonomic balance, rehabilitation and personal injury care